Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Simple Blood Test Could Predict Kidney Disease Trajectories

By LabMedica International staff writers
Posted on 23 Jul 2025

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inherited condition that can lead to kidney failure. More...

Accurately predicting how the disease will progress is critical for selecting appropriate treatments and providing informed patient counselling. However, current prediction tools are often inadequate, relying on MRI scans or genetic testing, which are not always accessible. As a result, there is a need for more effective, widely applicable methods to determine disease progression. In a new study, researchers have discovered that specific proteins in the blood can indicate how rapidly kidney function is likely to decline, offering a promising testing alternative to existing methods.

In the study, researchers from the University of Cologne (Cologne, Germany) used mass spectrometry to analyze blood samples from one of the world’s largest and best-characterized ADPKD patient cohorts. They integrated a novel robotic pipeline to process more than 1,000 samples and generate a serum proteomics-based prediction model. This approach enabled them to identify 29 proteins involved in immune function, fat transport, and metabolism that are strongly associated with the rate of kidney function decline. The collaborative research also reflects joint efforts between clinician scientists and computational biologists to bridge laboratory discovery and clinical application.

Their findings, published in Nature Communications, confirm that blood proteins can serve as biomarkers for ADPKD progression and reveal underlying mechanisms of the disease. The study shows that proteomics not only improves prediction but also provides insights into biological processes that drive ADPKD. These biomarkers may help personalize care by identifying patients at higher risk and guiding treatment decisions earlier. The researchers now plan to explore how current therapies influence proteome patterns and to develop new proteome-based markers for routine clinical use.

"Our study shows that blood proteins can offer powerful clues about how fast a patient's kidney function is likely to decline, potentially allowing for more personalized care in the most common genetic cause of kidney failure, ADPKD," said Professor Dr. Roman-Ulrich Müller, principal investigator. “By identifying specific proteins linked to disease progression, we’ve taken a meaningful step towards more accurate and earlier prediction, beyond what current clinical tools can provide.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.